These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 11010827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [HIV-infection, AIDS and BCG vaccination].
    Toida I.
    Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adverse effects of bacille Calmette-Guerin vaccination in HIV-positive infants.
    Hussey G, Hawkridge T, Eley B, Nuttall J, Kibel M, Geiter L, Barker L, Behr M, Demers AM.
    Clin Infect Dis; 2004 May 01; 38(9):1333-4; author reply 1334-5. PubMed ID: 15127353
    [No Abstract] [Full Text] [Related]

  • 6. National study of adverse reactions after vaccination with bacille Calmette-Guérin.
    Turnbull FM, McIntyre PB, Achat HM, Wang H, Stapledon R, Gold M, Burgess MA.
    Clin Infect Dis; 2002 Feb 15; 34(4):447-53. PubMed ID: 11797170
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease.
    Tuber Lung Dis; 1994 Jun 15; 75(3):179-80. PubMed ID: 7919307
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
    Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS, Gie RP, Cotton MF, van Helden PD, Warren RM, Beyers N.
    Clin Infect Dis; 2006 Feb 15; 42(4):548-58. PubMed ID: 16421800
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The rate of adverse events following BCG vaccination in Poland.
    Krysztopa-Grzybowska K, Paradowska-Stankiewicz I, Lutyńska A.
    Przegl Epidemiol; 2012 Feb 15; 66(3):465-9. PubMed ID: 23230718
    [Abstract] [Full Text] [Related]

  • 15. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I.
    Przegl Epidemiol; 2002 Feb 15; 56(2):205-16. PubMed ID: 12371352
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, Beyers N.
    Vaccine; 2007 Jan 02; 25(1):14-8. PubMed ID: 16959383
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency.
    Sohail S, Afzal M, Anwar V, Shama Q.
    J Coll Physicians Surg Pak; 2014 Nov 02; 24 Suppl 3():S259-61. PubMed ID: 25518795
    [Abstract] [Full Text] [Related]

  • 20. Cutaneous complication after BCG vaccination: case report and review of the literature.
    Keijsers RR, Bovenschen HJ, Seyger MM.
    J Dermatolog Treat; 2011 Dec 02; 22(6):315-8. PubMed ID: 20964574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.